Search - tctmd.com

Displaying 61 - 80 of 142

Sort: Relevancy | Date

News Daily News

New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry

Caitlin E. Cox

November 30, 2017

News Daily News

Appropriate Use Criteria Released for Imaging in Valvular Heart Disease

Caitlin E. Cox

September 06, 2017

Presentation iASSESS 2017

Complications of Structural Heart Disease Intervention - Part 1

Presenter: George Hanzel

August 30, 2017

News Conference News ESC 2017

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

Shelley Wood

August 27, 2017

News Daily News

Ultrasound May Prove Useful in Softening Calcified Bioprosthetic Valves

Caitlin E. Cox

June 21, 2017

News Conference News TVT 2017

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

Shelley Wood

June 12, 2017

Presentation SWVS 2017

The New ASE Guidelines for Native Valvular Regurgitation

Presenter: William A. Zoghbi

May 05, 2017

News Daily News

Focused Update to Valve Guidelines Tackles Intermediate-Risk TAVR, Anticoagulation for A-fib

Todd Neale

March 15, 2017

News Conference News CRT 2017

Pressure Wire Helps Identify Severe Aortic Stenosis in Paradoxical Low-Flow/Low-Gradient Cases

Michael O'Riordan

February 21, 2017

News Conference News ISET 2017

Forging Into the Future: Debating the Merits of TAVR in Younger, Futile, and Lower-Risk Patients

Caitlin E. Cox

February 06, 2017

News Daily News

Transcatheter Valve-in-Ring for Failed Tricuspid Repair: New Hope for Patients With Few Options

Caitlin E. Cox

January 05, 2017

News Daily News

Women More Likely to be Alive 1 Year After TAVR: STS/ACC TVT Registry

Michael O'Riordan

December 19, 2016

News Daily News

TAVR as an Option for Intermediate-Risk Patients: Physicians Respond

Yael L. Maxwell

August 24, 2016

Presentation TVT 2016

Tricuspid VIV

Presenter: Danny Dvir

June 17, 2016

Presentation TVT 2016

Management Decisions in the Patient With Severe AS and Mitral Regurgitation

Presenter: Marco Barbanti

June 17, 2016

Presentation TVT 2016

TVT 1123: TAVR Valve Used to Treat Native Mitral Regurgitation A Hybrid Surgical Transcatheter Approach

Presenter: Creighton W. Don

June 16, 2016

News Daily News

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

Shelley Wood

June 14, 2016

News Conference News EuroPCR 2016

Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You?

Yael L. Maxwell

May 20, 2016

News Conference News EuroPCR 2016

Planned MitraClip Implantation Safe, Feasible After TAVR, Small Series Suggests

Yael L. Maxwell

May 20, 2016

News Conference News EuroPCR 2016

‘Obesity Paradox’ Alive, Well, and Mysterious After TAVR

Yael L. Maxwell

May 18, 2016

Advertisement

New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry

Appropriate Use Criteria Released for Imaging in Valvular Heart Disease

Complications of Structural Heart Disease Intervention - Part 1

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

Ultrasound May Prove Useful in Softening Calcified Bioprosthetic Valves

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

The New ASE Guidelines for Native Valvular Regurgitation

Focused Update to Valve Guidelines Tackles Intermediate-Risk TAVR, Anticoagulation for A-fib

Pressure Wire Helps Identify Severe Aortic Stenosis in Paradoxical Low-Flow/Low-Gradient Cases

Forging Into the Future: Debating the Merits of TAVR in Younger, Futile, and Lower-Risk Patients

Transcatheter Valve-in-Ring for Failed Tricuspid Repair: New Hope for Patients With Few Options

Women More Likely to be Alive 1 Year After TAVR: STS/ACC TVT Registry

TAVR as an Option for Intermediate-Risk Patients: Physicians Respond

Tricuspid VIV

Management Decisions in the Patient With Severe AS and Mitral Regurgitation

TVT 1123: TAVR Valve Used to Treat Native Mitral Regurgitation A Hybrid Surgical Transcatheter Approach

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You?

Planned MitraClip Implantation Safe, Feasible After TAVR, Small Series Suggests

‘Obesity Paradox’ Alive, Well, and Mysterious After TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content